Latest Headlines

  1. Cleanroom Leader AES Clean Technology Recognized For CleanLock Module System 9/23/2024

    Pharma Manufacturing announced the 2024 Pharma Innovation Award winners. This year’s winners consist of 13 products and technologies chosen by editors and industry reviewers.

  2. Syed T. Husain Appointed As Chief Executive Officer 9/19/2024

    BioCentriq announced that it has appointed Syed T. Husain as its new Chief Executive Officer (CEO) and as a member of the Board of Directors.

  3. Refeyn Establishes New Mass Photometry Scientific Advisory Board To Maximize Potential Of Transformative Technology 9/16/2024

    Mass photometry’s unique bioanalytical workflow capabilities recognized by the scientific community, with over 500 scientific publications in just six years.

  4. Novotech Wins Prestigious Brandon Hall Gold Award For CRA Monitoring Simulation Program Under Category Of Best Competencies And Skill Development 9/12/2024

    Novotech, a leading full-service clinical Contract Research Organization (CRO), is proud to announce that its Clinical Research Associate (CRA) Monitoring Simulation Program has been recognized with the Brandon Hall Gold Award in the category of Best Competencies and Skill Development. This program is now available to all relevant CRAs in Novotech.

  5. Novotech Appoints Dr. Yooni Kim As A New Executive Position Of Managing Director For APAC To Strengthen Global Expansion 9/11/2024

    Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024.

  6. Novotech Honored With Frost & Sullivan's 2024 Best Practices Company Of The Year Award For Leadership In Biotech CRO Services 9/10/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan. This recognition underscores Novotech’s commitment to accelerating clinical development for biotech companies through innovative solutions, advanced analytics, and a comprehensive global reach.

  7. Somite Therapeutics and OmniaBio Inc. Announce Collaboration To Advance Somite's Cell Therapy Flagship Program 9/9/2024

    Somite Therapeutics, a tech-bio company harnessing big data and AI to pioneer novel cell replacement therapies, and OmniaBio Inc., a technology-driven cell and gene therapy CDMO founded by CCRM, today announced a cell therapy development and manufacturing collaboration for producing SMT-M01, Somite’s flagship program for Duchenne muscular dystrophy (DMD).

  8. Novotech Unveils 2024 Report On Global Gastric Cancer Clinical Trials And Cutting-Edge Therapeutics 9/6/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Gastric Cancer- Global Clinical Trial Landscape (2024).

  9. Novotech Releases 2024 Report On Pancreatic Cancer Clinical Trials And Drug Development 9/5/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released its latest industry report, Pancreatic Cancer- Global Clinical Trial Landscape (2024).

  10. Avance Clinical GlobalReady Site Partnership Network Expands Rapidly To 2,000 Site Members 9/4/2024